Blog
RSS FeedPosted by Michael Wonder on 10 Oct 2022
Mental health funding of £1.8 million welcomed by NICE and MHRA to explore regulation of digital mental health tools
10 October 2022 - NICE and the MHRA have been awarded £1.8 million funding by Wellcome over three years to explore ...
Posted by Michael Wonder on 28 Jun 2022
The Innovative Medicines Fund - good news for patients but has an opportunity been missed to be more ambitious?
27 June 2022 - NHS England and Improvement has announced the launch of the Innovative Medicines Fund. The ABPI’s Director ...
Posted by Michael Wonder on 15 Jun 2022
Shionogi signs agreement with NHS England to begin an innovative subscription payment model for reimbursement of its antibiotic, Fetcroja (cefiderocol)
15 June 2022 - Shionogi recognises the UK’s leadership role in introducing the world’s first fully ‘delinked’ pilot reimbursement model; pull ...
Posted by Michael Wonder on 15 Jun 2022
England’s Innovative Medicines Fund hits another milestone
15 June 2022 - Just like the Cancer Drugs Fund, the time-limited fund for the most promising cancer drugs introduced ...
Posted by Michael Wonder on 22 Jul 2021
NHS England unveils new Innovative Medicine Fund
21 July 2021 - NHS England has unveiled its new Innovative Medicines Fund, to ensure patients have early access to ...
Posted by Michael Wonder on 22 Dec 2020
Shionogi’s novel antibiotic, Fetcroja (cefiderocol), has been selected by UK’S NICE/NHSE&I as part of an antimicrobial subscription style reimbursement model
21 December 2020 - NICE and the National Health Service England and Improvement have recognised the potential of Shionogi’s innovative ...
Posted by Michael Wonder on 30 Jun 2020
After years of feuds, Vertex and the U.K. government reach a deal over cystic fibrosis medicines
30 June 2020 - U.K. officials and Vertex Pharmaceuticals have finally put to rest a years-long battle over access to ...
Posted by Michael Wonder on 18 Jun 2020
UK launches world's first ‘subscription-style’ payment model for antibiotics
18 June 2020 - A government scheme to fuel the development of new antibiotics by offering to pay pharmaceutical companies ...
Posted by Michael Wonder on 22 Apr 2020
UK underinvested in health care, says pharma boss
22 April 2020 - The UK has underinvested in health care "over many years" which has hampered its ability to ...
Posted by Michael Wonder on 11 Sep 2019
Government injects £130 million into cancer & debilitating illnesses
11 September 2019 - The UK government has announced an investment of over £130 million for new tech to tackle ...
Posted by Michael Wonder on 21 Aug 2019
NHS to reimburse Hemlibra
21 August 2019 - NHS England has commissioned Roche and Chugai’s joint haemophilia A drug, Hemlibra (emicizumab), agreeing to fund ...
Posted by Michael Wonder on 06 Aug 2019
Boris pledges a £1.8 billion cash injection for the NHS
5 August 2019 - There’s nothing like the prospect of a general election to free up funding for the NHS, ...
Posted by Michael Wonder on 08 Jul 2019
AstraZeneca boss calls for NHS drug approval shake-up
5 July 2019 - AstraZeneca has called for a wholesale review of the way new drugs are paid for in ...
Posted by Michael Wonder on 15 May 2019
NHS chief hails SMA drug deal – and was that a swipe at Vertex?
15 May 2019 - Children in England with the rare muscle wasting disease spinal muscular atrophy will get access to ...
Posted by Michael Wonder on 01 May 2019
NHS England finalises procurement to eliminate hepatitis C
1 May 2019 - After lengthy negotiations and a court battle, NHS England has reached agreement with three drug companies ...